PRZOOM - /newswire/ -
Noida, Uttar Pradesh, India, 2010/12/16 - The domestic pharmaceutical industry in India is expected to grow at a CAGR of 13% during FY 2011-FY 2013, RNCOS identified.
Pharmaceutical has emerged as one of the leading industries in India. Growth in the Indian pharmaceutical industry can be attributed to several factors such as, growing middle class population, rapid urbanization, increase in lifestyle-related diseases, and acceptance of health insurance. India has witnessed rapid improvement in the medical infrastructure, with more and more private players taking a giant leap forward. Moreover, the industry is expected to witness consolidation in coming years, which will enable the pharmaceutical companies to diversify into extended pharmaceutical businesses through the entire value chain. According to our research report “Booming Pharma Sector in India”, domestic pharmaceutical industry is expected to grow at a CAGR of 13% during FY 2011-FY 2013.
Growth will gain impetus from soaring demand for generic pharmaceuticals that have seen open acceptance globally. Demand for generic will inflate due to regulatory initiatives taken by the developed countries to cut down healthcare budgets. Emerging sectors like, biogenerics and pharma packaging will also pave the way for the pharmaceutical market to continue its upward trend during the forecast period (FY 2010- FY 2013). Our report has studied the emerging sectors of the Indian pharmaceuticals market.
We have done an extensive research and analysis of various segments of the Indian pharmaceutical market. These segments include: Domestic & Export Market, Branded & Generics Drugs, Formulations & Bulk Drugs, etc. We have also analyzed acute segment and chronic segment. Our report also contains information about past, present, and future trends, with focus on entire structure, composition, and working of the pharmaceutical market. The report extensively discusses challenges expected to arise within and outside the pharmaceutical market.
The report also analyzes regulatory environment and distribution system to identify strength and weaknesses of the pharmaceutical market. It has thoroughly examined current market trends, industrial developments, and competitive landscape to enable clients understand the market structure and its progress in coming years. It also presents a brief overview of the demographics and healthcare profile to adjudge the pharmaceutical market in terms of demand, expenditure, and possible future direction.
RNCOS (rncos.com) specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.